We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Temporary Baldness Traced to Gene Malfunction

By Biotechdaily staff writers
Posted on 13 Jun 2002
Working with a mouse model that closely resembles human hereditary baldness, researchers have found that the keratin 17 gene (K-17) plays a crucial role in temporary hair loss in mice and in ectodermal dysplasia epithelial disorders in humans. More...
These findings were reported in the June 1, 2002, issue of Genes & Development.

Investigators developed a strain of mice lacking keratin-producing gene K-17, one of the nearly 30 keratin genes expressed in hair follicles. Growth of fur in these mice was temporarily disrupted. Whereas normal newborn mice develop their fur coat within three to seven days after birth, some newborn K17-deficient mice do not grow fur at all within the first few weeks of their lives. Other mice demonstrated lesser degrees of hair loss. A closer look revealed that the mice suffered from severe hair fragility and the premature death of hair-producing cells.

In humans inherited mutations in the keratin 17 gene cause two separate epithelial disorders related to ectodermal dysplasias. Although each disorder causes a different epithelial deformity, both share a tendency for hair follicle abnormalities. Furthermore, the hair abnormalities that occur in people with inherited K-17 mutations vary both in frequency and severity--just like those in mice lacking K-17.

As Dr. Pierre Coulombe of the Johns Hopkins School of Medicine (Baltimore, MD, USA) explains, this work represents a marked advance because "not only are the features of these mice very informative with regards to how hair tissue works and the role of keratin proteins in hair structure and growth, it also provides significant insight into the clinical heterogeneity of the skin diseases arising as a result of inherited mutations in the keratin 17 gene.” The research was conducted by Dr. Coulombe and colleagues at Johns Hopkins and the CNRS-Institut Pasteur (Paris, France).



Related Links:
Johns Hopkins University
Institut Pasteur

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.